Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations.

PloS one - 1 Jan 2024

Anandakrishnan Ramu, Shahidi Ryan, Dai Andrew, Antony Veneeth, Zyvoloski Ian J

Abstract excerpt

Early detection can significantly reduce mortality due to lung cancer. Presented here is an approach for developing a blood-based screening panel based on clonal hematopoietic mutations. Animal model studies suggest that clonal hematopoietic mutations in tumor infiltrating immune cells can modulate cancer progression, representing potential predictive biomarkers. The goal of this study was to determine if the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Lung Neoplasms

Share to Machine Learning

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 39172974
DOI: 10.1371/journal.pone.0307232
PMCID: PMC11341013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An approach for developing a blood-based screening panel for lung cancer based on clonal hematopoietic mutations.PMID 39172974Read ↗

Blood-based screening panel for lung cancer based on clonal hematopoietic mutationsSemantic proximity Read ↗

Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNASemantic proximity Read ↗

Molecular Testing in Lung Cancer: Recommendations and Update.Semantic proximity Read ↗

Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.Semantic proximity Read ↗

Clonal Hematopoiesis in Lung Cancer and Its Impact on Liquid Biopsy Based on Targeted Deep SequencingSemantic proximity Read ↗

Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolutionSemantic proximity Read ↗

Clonal Hematopoiesis and Risk of Incident Lung Cancer.Semantic proximity Read ↗

Clonal hematopoiesis in lung adenocarcinoma pathogenesis.Semantic proximity Read ↗

Clonal Hematopoiesis: A New Layer in the Liquid Biopsy Story in Lung Cancer.Semantic proximity Read ↗

Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burdenSemantic proximity Read ↗

Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden.Semantic proximity Read ↗

Towards the molecular era of discriminating multiple lung cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.